GSTM1 and Hyperglycemia: There were no significant differences in height, weight, body mass index (BMI), SBP, DBP, Killip class II, Killip class III, TNI, Myo, CK-MB, hemoglobin (Hb), platelets (PLT), aspartate aminotransferase (AST), serum creatinine (Scr), uric acid (UA), aspirin, β-blocker, statin, calcium channel blocker (CCB), furosemide, antisterone, CABG, triple-vessel lesions, and number of stents between the hyperglycemia group and the nonhyperglycemia group (P > 0.05) (Table 2).